A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study

Completed · Phase 2

Conditions studied: Major Cutaneous Abscess, Cellulitis, Erysipelas

In brief

Characterization of the safety profile of TR-701 Free Acid (FA) in patients with major cutaneous abscess or cellulitis/erysipelas.

Key facts

Study ID
NCT01519778
Run by
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
People needed
200
Starts
2012-02-15
Expected to finish
2012-08-27
Last updated by the study team
2018-08-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.